| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 50.561 | 152.246 | 147.190 | 139.131 |
| Total Income - EUR | - | - | - | - | - | - | 50.562 | 152.248 | 147.278 | 139.133 |
| Total Expenses - EUR | - | - | - | - | - | - | 39.433 | 107.200 | 93.287 | 92.300 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 11.129 | 45.048 | 53.991 | 46.833 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 10.623 | 43.525 | 52.518 | 39.339 |
| Employees | - | - | - | - | - | - | 11 | 12 | 11 | 11 |
Check the financial reports for the company - Dr Bodnar. Regenerol-Ghergulescu S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 750 | 748 | 716 |
| Current Assets | - | - | - | - | - | - | 15.826 | 50.660 | 17.925 | 9.477 |
| Inventories | - | - | - | - | - | - | 4.525 | 299 | 298 | 296 |
| Receivables | - | - | - | - | - | - | 6.699 | 252 | 9.058 | 298 |
| Cash | - | - | - | - | - | - | 4.602 | 50.110 | 8.570 | 8.883 |
| Shareholders Funds | - | - | - | - | - | - | 10.663 | 993 | 12.752 | -85 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 5.162 | 50.418 | 5.921 | 10.278 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr Bodnar. Regenerol-Ghergulescu S.r.l.